KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 26109640)

Published in J Immunol on June 24, 2015

Authors

Tiernan J Mulrooney1, Aaron C Zhang1, Yehuda Goldgur2, Jeanette E Boudreau1, Katharine C Hsu3

Author Affiliations

1: Immunology Program, Sloan Kettering Institute, New York, NY 10065;
2: Department of Structural Biology, Sloan Kettering Institute, New York, NY 10065;
3: Immunology Program, Sloan Kettering Institute, New York, NY 10065; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; and Weill Cornell Medical College, Cornell University, New York, NY 10065 hsuk@mskcc.org.

Articles cited by this

In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature (1986) 9.73

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity (1999) 6.80

Human NK cell education by inhibitory receptors for MHC class I. Immunity (2006) 6.73

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood (2001) 5.23

MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science (1991) 3.93

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med (1993) 3.59

Improving FRET dynamic range with bright green and red fluorescent proteins. Nat Methods (2012) 3.54

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med (2006) 3.50

The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med (1995) 3.43

Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity (1996) 3.33

Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity (1998) 2.95

HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A (1993) 2.91

Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol (1998) 2.79

NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med (1994) 2.61

Global diversity and evidence for coevolution of KIR and HLA. Nat Genet (2007) 2.40

Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol (2002) 2.38

Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet (2007) 2.36

Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol (2001) 2.02

Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature (2011) 1.94

Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90

The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol (2003) 1.89

DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J Exp Med (2003) 1.70

Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens (2007) 1.49

Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res (2009) 1.42

Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur J Immunol (2007) 1.35

Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immun (2008) 1.28

Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. Blood (2008) 1.20

The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J Exp Med (2002) 1.19

Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J Immunol (2012) 1.19

Variable NK cell receptors exemplified by human KIR3DL1/S1. J Immunol (2011) 1.12

CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur J Immunol (1997) 1.10

Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5. Immunogenetics (2008) 1.03

HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. PLoS Pathog (2012) 1.01

Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand. J Immunol (2013) 1.00

Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS One (2008) 0.99

A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain. J Immunol (2006) 0.95

Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J Immunol (2010) 0.95

Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity. J Immunol (2014) 0.94

Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1. J Immunol (2011) 0.94

Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles. PLoS One (2014) 0.88

DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells. J Leukoc Biol (2013) 0.86

KIR3DL1 genetic diversity and phenotypic variation in the Chinese Han population. Genes Immun (2013) 0.81

Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing. Methods Mol Biol (2012) 0.80